 |
|
 Rafael
Holdings is focused on development of novel cancer therapies. The company is a significant investor in two clinical
stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix
Pharmaceuticals Ltd. Through its wholly-owned Barer Institute subsidiary, the company is
developing a pipeline of compounds focused on the regulation of cancer
metabolism. The company also holds commercial
real estate assets in New Jersey and Jerusalem. |
|
|
